ProShares Ultra Nasdaq Biotechnology (BIB)

NASDAQ: BIB · Real-Time Price · USD
87.64
+3.33 (3.95%)
At close: Apr 14, 2026, 4:00 PM EDT
87.82
+0.18 (0.21%)
After-hours: Apr 14, 2026, 4:47 PM EDT
Assets$79.13M
Expense Ratio0.95%
PE Ration/a
Shares Out970,000
Dividend (ttm)$0.49
Dividend Yield0.56%
Ex-Dividend DateMar 25, 2026
Payout FrequencyQuarterly
Payout Ration/a
Volume13,764
Open85.65
Previous Close84.30
Day's Range85.65 - 87.79
52-Week Low39.47
52-Week High90.91
Beta1.36
Holdings265
Inception DateApr 8, 2010

About BIB

Fund Home Page

The ProShares Ultra Nasdaq Biotechnology (BIB) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index. The fund provides 2x daily exposure to a modified market-cap-weighted index of biotechnology and pharmaceutical companies listed on NASDAQ. BIB was launched on Apr 8, 2010 and is issued by ProShares.

Asset Class Equity
Category Trading--Leveraged Equity
Stock Exchange NASDAQ
Ticker Symbol BIB
ETF Provider ProShares
Index Tracked NASDAQ / Biotechnology

Top 10 Holdings

151.81% of assets
NameSymbolWeight
NASDAQ BIO INDEX SWAP BNP PARIBASn/a37.62%
NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NAn/a30.04%
NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NAn/a26.92%
NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONALn/a19.19%
NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALEn/a14.47%
Gilead Sciences, Inc.GILD5.10%
Amgen Inc.AMGN4.92%
Vertex Pharmaceuticals IncorporatedVRTX4.84%
NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AGn/a4.60%
Regeneron Pharmaceuticals, Inc.REGN4.11%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Mar 25, 2026$0.00714Mar 31, 2026
Dec 24, 2025$0.13464Dec 31, 2025
Sep 24, 2025$0.18054Sep 30, 2025
Jun 25, 2025$0.17058Jul 1, 2025
Mar 26, 2025$0.13094Apr 1, 2025
Dec 23, 2024$0.39644Dec 31, 2024
Full Dividend History

Performance

BIB had a total return of 119.64% in the past year, including dividends. Since the fund's inception, the average annual return has been 16.91%.